Track 3: Understanding the Constraints on Clinical Trials Inclusion Criteria, Control Groups, Blind
September 11, 2020
Related
Partnerships in Action — RARE-X Exchange
Partnerships in Action was part of the 2024 RARE Drug Development Symposium’s RARE-X Users Forum Moderator: Charlene […]
Read moreUnlocking Insights Together: The Power of Data Collaboration — RARE-X Exchange
Unlocking Insights Together: The Power of Data Collaboration was part of the 2024 RARE Drug Development Symposium’s […]
Read moreIntegrating Clinical & Patient Reported Data: RARE-X Exchange
Integrating Clinical & Patient Reported Data was part of the 2024 RARE Drug Development Symposium’s RARE-X Users […]
Read moreRARE Pride: A Queer Conversation with André Marcel Harris
On June 11, 2024, Global Genes hosted a forum for stakeholders in the rare disease community to […]
Read moreRARE Pride: A Queer Conversation with Jas Madhavan
On June 11, 2024, Global Genes hosted a forum for stakeholders in the rare disease community to […]
Read moreRARE Pride: A Queer Conversation with Daniel Price
On June 11, 2024, Global Genes hosted a forum for stakeholders in the rare disease community to […]
Read moreRARE Pride: A Queer Conversation with Grayson Schultz
On June 11, 2024, Global Genes hosted a forum for stakeholders in the rare disease community to […]
Read moreRARE Pride: A Queer Conversation with Nate Milam
On June 11, 2024, Global Genes hosted a forum for stakeholders in the rare disease community to […]
Read moreRARE Pride: A Queer Conversation with Cory Lewis
On June 11, 2024, Global Genes hosted a forum for stakeholders in the rare disease community to […]
Read more